348
Views
6
CrossRef citations to date
0
Altmetric
Original

Avascular osteonecrosis after hyperthermia in children and adolescents with pelvic malignancies: A retrospective analysis of potential risk factors

, , , , , , , , & , MD show all
Pages 451-461 | Received 11 Oct 2005, Accepted 30 Jun 2006, Published online: 09 Jul 2009

References

  • Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345: 540–543
  • Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, Liu FF, Goodman P, Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996; 35: 731–744
  • Wessalowski R. Regionale Tiefenhyperthermie und Chemotherapie bei Tumoren von Kindern und Erwachsenen. Experimentelle und klinische Untersuchungen. Shaker Verlag, Aachen 2002
  • Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18
  • van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000; 355: 1119–1125
  • Issels RD, Prenninger SW, Nagele A, Boehm E, Sauer H, Jauch KW, Denecke H, Berger H, Peter K, Wilmanns W. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study. J Clin Oncol 1990; 8: 1818–1829
  • Wessalowski R, Schneider DT, Mils O, Hannen M, Calaminus G, Engelbrecht V, Pape H, Willers R, Engert J, Harms D, Göbel U. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin Padiatr 2003; 215: 303–309
  • Issels R. Hyperthermia combined with chemotherapy—biological rationale, clinical application, and treatment results. Onkologie 1999; 22: 374–381
  • Schlemmer M, Wendtner CM, Issels RD. Ifosfamide with regional hyperthermia in soft-tissue sarcomas. Oncology 2003; 65(Suppl 2)76–79
  • Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R. In vitro test-system for chemo- and thermosensitivity: An analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology. Klin Padiatr 2002; 214: 223–229
  • van der Zee J. Heating the patient: A promising approach?. Ann Oncol 2002; 13: 1173–1184
  • van der Zee J, Veeze-Kuijpers B, Wiggers T, van de Merwe SA, Treurniet-Donker AD. Risk of tumour growth along thermometry catheter trace: A case report. Int J Hyperthermia 1992; 8: 621–624
  • Haveman J, Van Der Zee J, Wondergem J, Hoogeveen JF, Hulshof MC. Effects of hyperthermia on the peripheral nervous system: A review. Int J Hyperthermia 2004; 20: 371–391
  • Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL-BFM 95. Pediatr Blood Cancer 2005; 44: 220–225
  • Langebrake C, Reinhardt D, Ritter J. Minimising the long-term adverse effects of childhood leukaemia therapy. Drug Saf 2002; 25: 1057–1077
  • Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M, Koward S, Ribeiro R, Sandlund JT, Pui CH, Kaste SC. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004; 22: 3930–3936
  • Winquist EW, Bauman GS, Balogh J. Nontraumatic osteonecrosis after chemotherapy for testicular cancer: A systematic review. Am J Clin Oncol 2001; 24: 603–606
  • Dewey WC. Interaction of heat with radiation and chemotherapy. Cancer Res 1984; 44(Suppl)4714s–4720s
  • Lagendijk JJ, Van Rhoon GC, Hornsleth SN, Wust P, De Leeuw AC, Schneider CJ, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998; 14: 125–133
  • Edelstein-Keshet L, Dewhirst MW, Oleson JR, Samulski TV. Characterization of tumour temperature distributions in hyperthermia based on assumed mathematical forms. Int J Hyperthermia 1989; 5: 757–777
  • Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, Santoro N, Tamaro P, Lippi A, Gallisai D, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003; 88: 747–753
  • Mattano Jr LA, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the Children's Cancer Group. J Clin Oncol 2000; 18: 3262–3272
  • Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001; 19: 3066–3072
  • Bernbeck B, Christaras A, Krauth K, Lentrodt S, Strelow H, Schaper J, Janssen G, Mödder U, Göbel U. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): An approach to cure?—BME/AON and hyperbaric oxygen therapy as a treatment modality. Klin Padiatr 2004; 216: 370–378
  • Raab P, Kuhl J, Krauspe R. [Multifocal osteonecrosis in children and adolescents after polychemotherapy]. Z Orthop Ihre Grenzgeb 1997; 135: 444–450
  • Göbel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 2000; 11: 263–271
  • Geetha N, Kumary PK, Ramachandran K, Nair MK. Avascular necrosis of the femoral head in neuroblastoma: A case report. Pediatr Hematol Oncol 1998; 15: 443–446
  • Ishii E, Yoshida N, Miyazaki S. Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy. Eur J Pediatr 1984; 143: 152–153
  • Fisher RL. An epidemiological study of Legg-Perthes disease. J Bone Joint Surg Am 1972; 54: 769–778
  • Molloy MK, MacMahon B. Incidence of Legg-Perthes disease (osteochondritis deformans). N Engl J Med 1966; 275: 988–990
  • Aigner C, Ehall R, Stampfel O. [Osteoradionecrosis of the hip joint]. Z Orthop Ihre Grenzgeb 1995; 133: 467–473
  • Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Korholz D, Graf N, Heise U, Jürgens H, Kotz R, et al. Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9: 893–899
  • Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: A final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706–3719
  • Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
  • Körholz D, Bruder M, Engelbrecht V, Ruther W, Göbel U. Aseptic osteonecrosis in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1998; 15: 307–315
  • Jäger M, Werner A, Lentrodt S, Mödder U, Krauspe R. [Pain management in non-juvenile, aseptic osteonecrosis]. Schmerz 2004; 18: 481–491

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.